Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,846 shares at $25.07 ($71K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
Open-market sale of $71k DCPH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.07 | 1,373 | $34K | 48.2% |
| 2 | $25.07 | 1,373 | $34K | 48.2% |
| 3 | $25.00 | 100 | $3K | 3.5% |
| Total | $25.07 avg | 2,846 | $71K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |